Comment on: "A Systematic Review of Sodium Zirconium Cyclosilicate for Hyperkalemia Management in Heart Failure and Chronic Kidney Disease"
DOI:
https://doi.org/10.5281/zenodo.21808555Abstract
n/a
References
Çankaya E, Gürlek Akol Z, Akgür S. A systematic review of sodium zirconium cyclosilicate for hyperkalemia management in heart failure and chronic kidney disease. J Eur Int Med Prof. 2026;4(1):32-40. https://doi.org/10.5281/zenodo.18461609
Desai NR, Kammerer J, Budden J, Olopoenia A, Tysseling A, Gordon A. The Association of Heart Failure and Edema Events between Patients Initiating Sodium Zirconium Cyclosilicate or Patiromer. Kidney360. 2024;5(12):1835-1843. doi:10.34067/KID.0000000586
Zhuo M, Kim SC, Patorno E, Paik JM. Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer. J Card Fail. 2022;28(9):1414-1423. doi:10.1016/j.cardfail.2022.04.003
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Gamze Ergün

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All articles published in this journal are licensed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).








